Exxon Mobil Corp XOM
We take great care to ensure that the data presented and summarized in this overview for EXXON MOBIL CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding XOM
View all-
Vanguard Group Inc Valley Forge, PA384MShares$45.1 Billion0.9% of portfolio
-
Black Rock Inc. New York, NY273MShares$32 Billion0.75% of portfolio
-
State Street Corp Boston, MA210MShares$24.7 Billion1.11% of portfolio
-
Jpmorgan Chase & CO New York, NY80.1MShares$9.41 Billion0.85% of portfolio
-
Geode Capital Management, LLC Boston, MA78.9MShares$9.26 Billion0.86% of portfolio
-
Bank Of America Corp Charlotte, NC65.8MShares$7.73 Billion0.72% of portfolio
-
Morgan Stanley New York, NY57.4MShares$6.74 Billion0.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD45.2MShares$5.3 Billion0.64% of portfolio
-
Northern Trust Corp Chicago, IL40.1MShares$4.71 Billion0.82% of portfolio
-
Dimensional Fund Advisors LP Austin, TX31.5MShares$3.69 Billion1.01% of portfolio
Latest Institutional Activity in XOM
Top Purchases
Top Sells
About XOM
Exxon Mobil Corporation explores for and produces crude oil and natural gas in the United States and internationally. It operates through Upstream, Downstream, and Chemical segments. The company is also involved in the manufacture, trade, transport, and sale of crude oil, natural gas, petroleum products, petrochemicals, and other specialty products; manufactures and sells petrochemicals, including olefins, polyolefins, aromatics, and various other petrochemicals; and captures and stores carbon, hydrogen, and biofuels. As of December 31, 2021, it had approximately 20,528 net operated wells with proved reserves. The company was founded in 1870 and is headquartered in Irving, Texas.
Insider Transactions at XOM
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2024
|
Maria S. Dreyfus Director |
BUY
Open market or private purchase
|
Direct |
18,310
+33.87%
|
$1,995,790
$109.25 P/Share
|
|
May 24
2024
|
Neil A Chapman Senior Vice President |
SELL
Bona fide gift
|
Direct |
889
-0.11%
|
-
|
|
May 03
2024
|
Gregory James Goff Director |
BUY
Grant, award, or other acquisition
|
Indirect |
8
+1.86%
|
-
|
|
May 03
2024
|
Gregory James Goff Director |
BUY
Grant, award, or other acquisition
|
Direct |
945
+3.44%
|
-
|
|
May 03
2024
|
Maria S. Dreyfus Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+31.44%
|
-
|
|
Apr 29
2024
|
Darrin L Talley Vice President |
SELL
Open market or private sale
|
Indirect |
2,426
-8.73%
|
$288,694
$119.01 P/Share
|
|
Mar 19
2024
|
Darrin L Talley Vice President |
SELL
Open market or private sale
|
Indirect |
2,400
-7.95%
|
$271,200
$113.33 P/Share
|
|
Feb 22
2024
|
Darrin L Talley Vice President |
SELL
Open market or private sale
|
Indirect |
2,400
-7.36%
|
$252,000
$105.0 P/Share
|
|
Jan 02
2024
|
Dina H. Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+50.0%
|
-
|
|
Jan 02
2024
|
Jeffrey W Ubben Director |
SELL
Grant, award, or other acquisition
|
Direct |
2,500
-13.89%
|
-
|
|
Jan 02
2024
|
Lawrence W Kellner Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+19.23%
|
-
|
|
Jan 02
2024
|
Alexander Karsner Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+7.14%
|
-
|
|
Jan 02
2024
|
Steven A Kandarian Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+9.8%
|
-
|
|
Jan 02
2024
|
Joseph L Hooley Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+12.2%
|
-
|
|
Jan 02
2024
|
Kaisa Hietala Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+13.89%
|
-
|
|
Jan 02
2024
|
Gregory James Goff Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+8.92%
|
-
|
|
Jan 02
2024
|
John D Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+18.87%
|
-
|
|
Jan 02
2024
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+8.2%
|
-
|
|
Jan 02
2024
|
Susan K Avery Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+8.93%
|
-
|
|
Jan 02
2024
|
Angelakis Michael J Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+6.58%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 1.09M shares |
|---|---|
| Bona fide gift | 993 shares |
| Open market or private purchase | 918K shares |
| Payment of exercise price or tax liability | 94.2K shares |
|---|---|
| Open market or private sale | 2.1M shares |
| Bona fide gift | 7.67K shares |
| Grant, award, or other acquisition | 2.5K shares |